Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition
Authors:
- Christof HiebelCHChristof Hiebel
- Regina HansteinRHRegina Hanstein
- Martin PurrioMPMartin Purrio
- Heike NagelHNHeike Nagel
- Andrea ConradACAndrea Conrad
- Beat LutzBLBeat Lutz
- Christian BehlChristian Behl
- Angela B. ClementACAngela B. Clement
- 1 November 2013
- journal article
- Published by Elsevier in Neurobiology of Aging
- Vol. 34 (11) , 2574-2584
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- CB1 Agonist ACEA Protects Neurons and Reduces the Cognitive Impairment of AβPP/PS1 MiceJournal of Alzheimer’s Disease, 2012
- Mitochondrial CB1 receptors regulate neuronal energy metabolismNature Neuroscience, 2012
- Change in tau phosphorylation associated with neurodegeneration in the ME7 model of prion diseaseBiochemical Society Transactions, 2010
- The Role of the Endocannabinoid System in Alzheimers Disease: Facts and HypothesesCurrent Pharmaceutical Design, 2008
- 96-Well Electroporation Method for Transfection of Mammalian Central NeuronsBioTechniques, 2006
- Induction of Glial Fibrillary Acidic Protein Expression in Astrocytes by Nitric OxideThe Journal of Neuroscience, 2006
- Neocortical synaptic bouton number is maintained despite robust amyloid deposition in APP23 transgenic miceNeurobiology of Aging, 2005
- Cannabinoid CB2Receptors and Fatty Acid Amide Hydrolase Are Selectively Overexpressed in Neuritic Plaque-Associated Glia in Alzheimer's Disease BrainsThe Journal of Neuroscience, 2003
- Distribution of Alzheimer‐type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's diseaseNeurology, 1992
- Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's diseaseNeurology, 1992